Virtu Financial LLC decreased its holdings in shares of Icon Plc (NASDAQ:ICLR) by 16.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,533 shares of the medical research company’s stock after selling 481 shares during the quarter. Virtu Financial LLC’s holdings in Icon were worth $389,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the company. Marietta Investment Partners LLC grew its holdings in shares of Icon by 18.3% during the second quarter. Marietta Investment Partners LLC now owns 2,472 shares of the medical research company’s stock worth $328,000 after buying an additional 382 shares in the last quarter. DekaBank Deutsche Girozentrale grew its holdings in shares of Icon by 119.7% during the third quarter. DekaBank Deutsche Girozentrale now owns 769 shares of the medical research company’s stock worth $113,000 after buying an additional 419 shares in the last quarter. BB&T Corp grew its holdings in shares of Icon by 11.5% during the third quarter. BB&T Corp now owns 4,116 shares of the medical research company’s stock worth $632,000 after buying an additional 425 shares in the last quarter. Comerica Bank grew its holdings in shares of Icon by 9.1% during the second quarter. Comerica Bank now owns 5,872 shares of the medical research company’s stock worth $806,000 after buying an additional 490 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Icon by 2.8% during the second quarter. Oppenheimer Asset Management Inc. now owns 18,239 shares of the medical research company’s stock worth $2,418,000 after buying an additional 494 shares in the last quarter. 86.54% of the stock is owned by institutional investors and hedge funds.
Shares of ICLR opened at $138.11 on Thursday. The company has a quick ratio of 2.17, a current ratio of 2.17 and a debt-to-equity ratio of 0.26. Icon Plc has a 12-month low of $101.22 and a 12-month high of $155.33. The stock has a market capitalization of $7.48 billion, a P/E ratio of 25.62, a PEG ratio of 1.98 and a beta of 0.55.
Icon (NASDAQ:ICLR) last announced its quarterly earnings data on Wednesday, October 24th. The medical research company reported $1.54 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.54. Icon had a net margin of 12.88% and a return on equity of 26.08%. The firm had revenue of $655.02 million during the quarter, compared to analyst estimates of $654.66 million. Equities research analysts anticipate that Icon Plc will post 6.08 EPS for the current year.
A number of research firms have recently issued reports on ICLR. BidaskClub raised shares of Icon from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 1st. UBS Group set a $136.00 target price on shares of Icon and gave the stock a “sell” rating in a report on Saturday, October 27th. Evercore ISI raised shares of Icon from an “in-line” rating to an “outperform” rating in a report on Friday, October 26th. Zacks Investment Research lowered shares of Icon from a “hold” rating to a “sell” rating in a report on Wednesday, October 24th. Finally, Robert W. Baird upped their price objective on shares of Icon from $154.00 to $157.00 and gave the company an “outperform” rating in a report on Tuesday, September 11th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $148.00.
TRADEMARK VIOLATION NOTICE: “Virtu Financial LLC Reduces Stake in Icon Plc (ICLR)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/12/13/virtu-financial-llc-reduces-stake-in-icon-plc-iclr.html.
Icon Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Further Reading: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.